爱必妥治疗31例头颈部肿瘤的护理体会

下载PDF

导出

摘要总结了使用爱必妥治疗31例头颈部肿瘤患者的护理体会,主要包括严格掌握适应征、抢救药品的准备、使用护理、副反应的观察与护理等。本研究31例患者共输注181次爱必妥,治疗全程实施正确、无护理不良事件发生。认为爱必妥作为头颈部肿瘤患者的有效治疗药物,其正确的全程护理是使用爱必妥的关键。

作者肖建红陆嘉红

机构地区江苏省无锡市第四人民医院头颈部肿瘤放疗科

出处《当代护士（下旬刊）》 2013年第6期88-89,共2页 Modern Nurse

关键词头颈部肿瘤爱必妥护理

参考文献6

1Specenier P, Vermorken JB. Cetuximab in the treatment of squamous cell carcinoma of the head and neck[J].Expert Rev Anticancer Ther,2011,11(4):511-524.
2Rivera F, Garcia-Castano A, Vega N, et al. Cetuximab in metastatic or recurrent head and neck cancer:the EXTREME trial[J].Expert Rev Anticancer Ther,2009,9(10):1421-1428.
3Kabolizadeh P, Kubicek GJ, Heron DE, et al. The role of ce- tuximab in the management of head and neck cancers[J].Expert Opin Biol Ther,2012,12(4):517-528.
4张晓东,张小田,李洁,李健,周军,李燕,沈琳.西妥昔单抗急性输液反应的临床对策[J].肿瘤,2008,28(1):77-79. 被引量：4
5Saif MW, Shah M. Kras mutations in colorectal cancer:a practice changing discovery[J].Clin Adv Hematol 0neol,2009,7(1):45-53.
6Fakih MG, Wilding G, Lombardo J. Cetuximab induced hypomagnesemia in patients with coloreetal cancer[J]. Clin Colorectal Cancer,2006,6(2): 152- 156.

1National Cancer Institute-Cancer Therapy Evaluation Program. CTCAE v3.0 [ S/OL]. ( 2005-12-29 ) [ 2007-06-11 ] http://ctep. cancer. gov/reporting/ ctc_v3.0. html.
2CUNNINGHAM D, HUMBLET Y, SIENA S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer[J]. N Engl J Med, 2004,351 (4) : 337 -345.
3LENZ H J, VAN CUTSEM E, KHAMBATA-FORD S, et al. Multicenter phase Ⅱ and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines[J]. J Clin Oncol, 2006,24(30) :4914-4921.
4SALTZ LB, MEROPOL N J, LOEHRER PJ, et al. Phase Ⅱ trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor[ J ]. J Clin Oncol, 2004, 22(7) :1201-1208.
5NEEDLE M N. Safety experience with IMCC225, an anti-epidermal growth factor receptor antibody[ J]. Semin Oncol, 2002,29(5 Suppl 14) :55-60.
6ROBERT F, EZEKIEL M P, SPENCER SA, et al. Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer[J]. J Clin Oncol, 2001, 19(13) :3234-3243.
7PATEL D D, GOLDBERG R M. Cetuximab-associated infusion reactions : pathology and management [ J ]. Oncology, 2006,20 ( 11 ) :1373-1382.
8THOMAS M. Cetuximab: Adverse event profile and recommendations for toxicity management [ J ]. Clin J Oncol Nurs, 2005, 9 (3) :332-338.

当代护士（下旬刊）

2013年第6期

内容加载中请稍等...